About Hanh

This author has not yet filled in any details.
So far Hanh has created 117 blog entries.

PRESS RELEASE: IVI Responds to HHS’ Blueprint Saying Lowering Healthcare Costs Requires Improving Value Assessment

IVI Says Moving Beyond Cost Effectiveness by Evaluating Treatments Based on Unique Patient Characteristics and Preferences is Imperative Los Angeles, CA – July 16, 2018 -- If we are going to truly harness data to lower healthcare costs while accelerating and rewarding innovation that benefits patients, then defining and assessing value in healthcare must [...]

2018-07-17T09:48:32+00:00July 16th, 2018|IVI News, Press|

Current Problems with Value Assessments and Ideas for Improvement

In an op-ed published by Fierce Healthcare, Director of Scientific Communications, Mark Linthicum discusses current shortfalls of value assessment and what is needed to move to value assessment 2.0. Read the full article here.

2018-07-11T14:10:32+00:00July 11th, 2018|Viewpoints|

PRESS RELEASE: Why IVI’s Next Open-Source Modeling Platform Will Focus on Value in Lung Cancer

Los Angeles, CA -- June 20, 2018 -- Oncology is both an area of immense clinical need and a primary driver of healthcare spending. As a result, cancer care is a focus of extensive debate around value. In short, the field of oncology offers a unique opportunity to develop patient-centered, robust, and flexible models [...]

2018-06-20T14:22:35+00:00June 20th, 2018|IVI News, Press|

PRESS RELEASE: IVI’s Open-Source Value Project Produces Actionable Data on Value of Rheumatology Treatment Sequencing Designs

Washington, D.C. -- June 14, 2018 -- Measuring value in healthcare, which traditionally takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to healthcare decision makers, according to a new article published today in the Journal [...]

2018-06-20T14:12:50+00:00June 14th, 2018|IVI News, Press|

IVI Leadership Invited to Speak at the 2018 BIO International Convention

The 2018 BIO International Convention will be held in Boston, MA from June 4th through June 7th. IVI’s Jennifer Bright (Acting Executive Director) and Mark Linthicum (Director of Scientific Communications) are among the speakers invited to the 2018 BIO International Convention, where they will be discussing value assessment frameworks and patient value. The description of [...]

2018-06-15T12:16:55+00:00June 4th, 2018|Event, IVI News|

IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles

To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the actions IVI takes to involve patients and patient organizations early and often in research, model development and other projects, and establish a basis [...]

2018-05-03T16:33:42+00:00April 17th, 2018|IVI News|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model [...]

2018-05-03T16:32:26+00:00April 16th, 2018|IVI News, Research|

IVI-RA Value Tool Featured on ISPOR Student Webinar Series

Devin Incerti, Lead Economist on IVI's Open-Source Value Project, will be presenting the IVI-RA Value Tool as one of ISPOR's featured student webinars. See below for the full description and details on the webinar, as well as the registration link. WEBINAR: Developing Flexible, Iterative, and Transparent Decision Models: A Detailed Look at the Rheumatoid Arthritis [...]

2018-05-03T16:31:29+00:00April 15th, 2018|Event, IVI News|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play in determining value for different stakeholders, and how unique, multi-stakeholder efforts can make formularies more patient-centered. Read the full article [...]

2018-04-16T12:22:51+00:00April 11th, 2018|Viewpoints|

PRESS RELEASE: IVI Responds to ICER’s New Pilot Program

The Institute for Clinical Economic Review (ICER) recently launched a new pilot program that will allow more extensive evaluation of draft economic models used in ICER's reports. In response to ICER's new program, Mark Linthicum, Director of Scientific Communications for the Innovation and Value Initiative (IVI), commented: "The Innovation and Value Initiative (IVI) is working diligently [...]

2018-06-20T14:19:06+00:00April 3rd, 2018|IVI News, Press|